Jan 1

Featured 10:15 am - 11:00 am

VASCEPA® (icosapent ethyl)—Elevating the Standard of Care

Feb 16

Virtual Event

Featured February 16, 2021 @ 8:00 am - April 15, 2021 @ 10:00 am CST

What’s New with GLP-1?

Mar 17

March 17, 2021 @ 10:15 am - June 13, 2021 @ 11:00 am CDT

Enabling Telemedicine and Remote Monitoring With the Freestyle Libre 14 Day System (This Product Theater is Pre-Recorded)

Jun 12

2:00 pm - 3:40 pm

Ethnic and Racial Disparities in Maternal, Perinatal, and Neonatal Mortality

Jun 12

2:00 pm - 4:00 pm

Doing Better for Diabetes and Chronic Kidney Disease (CKD)

Jun 12

Featured 2:00 pm - 4:00 pm

Transitions in Diabetes

Jun 12

2:00 pm - 4:00 pm

Using Technologies to Track Physical Activity and Improve Health

Jun 12

2:00 pm - 4:00 pm

Adipose Innervation

Jun 12

2:00 pm - 4:00 pm

Which Diet Is Best for Treatment of Diabetes and Obesity?

Jun 12

2:00 pm - 4:00 pm

What’s New with Beta-Cell Replacement?

Jun 12

4:15 pm - 5:55 pm

Functional Cure of Type 1 Diabetes—Where Shall We Take the Islet Cells From?

Jun 12

4:15 pm - 6:15 pm

Tailoring Treatment Options Based on Diabetes Comorbidities

Jun 12

4:15 pm - 6:15 pm

Taking the Technology Plunge—Integrating Digital Technology into Practice

Jun 12

Featured 4:45 pm - 5:15 pm

Patients with Low Estimated Glomerular Filtration Rate

Jun 13

8:00 am - 10:00 am

ADA Diabetes Care Symposium—Long-Term Perspectives on Study and Care of Diabetes

Jun 13

8:00 am - 10:00 am

Culinary Medicine—Its Role in the Prevention and Treatment of Obesity, Diabetes, and Metabolic Syndrome

Jun 13

8:00 am - 10:00 am

Reduction of Hypoglycemia by New Therapies in Clinical Trials—Overestimated, Underestimated, or Both?

Jun 13

8:00 am - 10:00 am

ADA Education Recognition Program Symposium—Clinical Considerations for Safe, Cultural, Spiritual, and Therapeutic Fasting among People with Diabetes

Jun 13

8:00 am - 10:00 am

Engaging the Immune System to Protect Beta Cells

Jun 13

8:00 am - 10:00 am

The Impact of Environmental Temperature on Metabolic Regulation

Jun 13

12:30 pm - 1:30 pm

Thinking Beyond Glycemia—The Importance of Managing Heart Failure Risks in Type 2 Diabetes (This Product Theater is Pre-Recorded)

Jun 13

12:30 pm - 1:30 pm

Are We Waiting Too Long to Start a GLP-1RA in Adult Patients with T2D? (For Non-U.S. HCPs Only) (This Product Theater is Pre-Recorded)

Jun 13

1:45 pm - 3:45 pm

Maximizing Long-Term Weight Loss Maintenance with Lifestyle Changes

Jun 13

1:45 pm - 3:45 pm

The New Physiology—Organs in a Dish—Promises, Pitfalls, and Potential Clinical Applications

Jun 13

1:45 pm - 3:45 pm

Clinical Management of Diabetic Neuropathies in 2020

Jun 13

1:45 pm - 3:45 pm

Slicing and Dicing—Prohormone Processing in Diabetes

Jun 13

1:45 pm - 3:45 pm

Joint ADA/ISPAD Symposium—Hemoglobin A1C vs. Time-in-Range as the Primary Metric in Pediatric Diabetes?

Jun 13

4:00 pm - 5:15 pm

DAPA-HF Update—Have We Lost SGLT2 Inhibitors to Cardiologists?!

Jun 13

4:00 pm - 5:40 pm

Diabetes in Sub-Saharan Africa—Challenges and Opportunities

Jun 13

4:00 pm - 5:50 pm

Diabetes Devices and Digital Technologies—Who Does It Help the Most (and Least)? (With Richard R. Rubin Award Lecture)

Jun 13

4:00 pm - 5:50 pm

Chair

Jun 13

Featured 4:00 pm - 6:00 pm

Immunity, Metabolism, and Diabetes

Jun 13

4:00 pm - 6:00 pm

Dilemmas in Diabetic Foot Infection Management

Jun 13

4:00 pm - 6:00 pm

Myosteatosis—What Happens When Skeletal Muscle Is Marbled Like Steak?

Jun 13

4:00 pm - 6:00 pm

Chair

Jun 13

5:10 pm - 5:30 pm

How Tech May Unintentionally Widen the Health Disparities Gap

Jun 14

8:00 am - 10:00 am

Adjunctive Glucose-Lowering Therapies for Adults with Type 1 Diabetes—Evidence

Jun 14

8:00 am - 10:00 am

The Islet under Duress in Type 1 Diabetes

Jun 14

8:00 am - 10:00 am

Mind the Clock—Timing of Feeding in the Control of Metabolic Health

Jun 14

8:00 am - 10:00 am

Pancreas Transplantation—Why Aren’t We Doing More?

Jun 14

8:00 am - 10:00 am

Lifestyle Interventions for Type 2 Diabetes Remission

Jun 14

8:00 am - 10:00 am

ADA Diabetes Symposium—Unraveling the Heterogeneity in Type 2 Diabetes

Jun 14

Virtual Event

Featured 10:15 am - 11:00 am

VASCEPA® (icosapent ethyl)—Elevating the Standard of Care (This Product Theater is Presented Live)

Jun 14

10:15 am - 11:00 am

Considerations for Glycemic Control—Choosing a Basal Insulin for Patients with Diabetes (This Product Theater is Pre-Recorded)

Jun 14

12:00 pm - 1:00 pm

New Insights from the Restoring Insulin Secretion (RISE) Study—Differences between Adults and Youth with Prediabetes and Type 2 Diabetes

Jun 14

12:30 pm - 1:30 pm

Renal and Cardiovascular Outcomes in Adults with Diabetic Nephropathy (i.e., DKD) and Type 2 Diabetes (U.S. Only) (This Product Theater is Presented Live. It Will Not Be Available On Demand)

Jun 14

12:30 pm - 1:30 pm

Understanding Chronic Kidney Disease in Type 2 Diabetes—The Risks, Recognition, and Clinical Management (This Product Theater is Presented Live. It Will Not Be Available On Demand)

Jun 14

12:30 pm - 1:30 pm

Break the Sequential T2DM Treatment Pattern in Adult Patients with High A1C (≥9%) on OADs, or Uncontrolled on GLP-1 Ras, and get them to Goal (This Product Theater is Pre-Recorded)

Jun 14

2:15 pm - 4:15 pm

Not Your Grandmother’s Transcription Factors—New Insights into Genomic Regulation of Beta-Cell Function

Jun 14

2:15 pm - 4:15 pm

Low-Carb Diets in Pediatric Type 1 Diabetes—Pros and Cons

Jun 14

2:15 pm - 4:15 pm

Joint ADA/Diabetes UK Symposium—Islet Transplantation—Quo Vadis?

Jun 14

3:00 pm - 3:45 pm

Simplifying Diabetes Management—Advancing Innovation Across Outcomes, Patient Experience, and Support with the Guardian™ Connect Continuous Glucose Monitoring (CGM) System (U.S. Only) (This Product Theater is Pre-Recorded)

Jun 14

4:30 pm - 6:00 pm

Physiological Mechanisms of Remission of Type 2 Diabetes

Jun 14

4:30 pm - 6:10 pm

Menopause and Diabetes

Jun 14

4:30 pm - 6:30 pm

What Will Be the Impact of Proposed Health Policy Changes on Diabetes Care?

Jun 14

4:30 pm - 6:30 pm

Joint ADA/ASN Symposium—Targeting Diabetic Kidney Disease (DKD)—Are We Ready for Precision Medicine Trials?

Jun 14

4:30 pm - 6:30 pm

Nonalcoholic Steatohepatitis (NASH)—Emerging Concepts and Opportunities

Jun 14

Featured 4:30 pm - 6:30 pm

Population Health Efforts in the Prevention and Treatment of Diabetes

Jun 15

8:00 am - 10:00 am

Joint ADA/EASD Symposium—Leveraging Metabolism to Prevent, Treat, or Cure Type 1 Diabetes

Jun 15

8:00 am - 10:00 am

From Genome-Wide Association Studies to Multiomics—Defining Diabetes Risk and Clinical Relevance

Jun 15

8:00 am - 10:00 am

Utilizing Diabetes Technology in the Real World—Tools of the Trade

Jun 15

8:00 am - 10:00 am

How Do GLP-1 Receptor Agonists Provide Cardioprotection?

Jun 15

8:00 am - 10:00 am

Trouble in the Neighborhood—Endocrine/Exocrine Interactions in Diabetes

Jun 15

8:00 am - 10:00 am

Update from the TEDDY Study

Jun 15

8:30 am - 9:00 am

Multiomic Approaches in Explaining Diabetes Risk

Jun 15

2:15 pm - 3:55 pm

Disparities in Diabetes and Diabetes Care—What Can We Do about It?

Jun 15

2:15 pm - 4:15 pm

Chinese Diabetes Society Symposium—Novel Antidiabetic Approaches and Potential Targets

Jun 15

2:15 pm - 4:15 pm

Artificial Intelligence (AI), Machine Learning, and Diabetes

Jun 15

2:15 pm - 4:15 pm

Physical Activity and Diabetes—When, How Much, Insulin Adjustments, and More

Jun 15

2:15 pm - 4:15 pm

Fetal Sex and Pregnancy Outcomes

Jun 15

2:15 pm - 4:15 pm

Twenty Years of Pediatric Diabetes Surveillance—What Do We Know and Why It Matters—The SEARCH for Diabetes in Youth Study

Jun 15

Featured 3:15 pm - 4:15 pm

Weekly Basal Insulin—The Wave of the Future?

Jun 15

4:30 pm - 6:10 pm

Novel Approaches for Cell and Tissue Interrogation—Using the Kidney as a Model

Jun 15

4:30 pm - 6:30 pm

Cognitive Function in Obesity and Appetite Regulation

Jun 15

5:50 pm - 6:10 pm

Lessons from Single Cell Genomics and Kidney Organoids

Jun 16

8:00 am - 9:40 am

Diabetes Meets the Sandman—Sleep, Diabetes, and Glycemic Management

Jun 16

8:00 am - 10:00 am

Economic Drivers of Obesity Treatment—From Individuals to Systems

Jun 16

8:00 am - 10:00 am

SGLT2 Inhibitors—How Do They Reduce Cardiorenal Disease?

Jun 16

8:00 am - 10:00 am

Immune Intervention During the Stages of Type 1 Diabetes Development—Type 1 Diabetes TrialNet

Jun 16

8:00 am - 10:00 am

New Data on Clinical Outcomes from the Diabetes Prevention Program Outcomes Study (DPPOS)

Jun 16

10:15 am - 12:15 pm

Results of the eValuation of ERTugliflozin EffIcacy and Safety CardioVascular Outcomes Trial (VERTIS-CV)